Loading
  • Main Menu
Caribbean Public Health Agency
  • Login
  • Home
  • Who We Are
    • About
    • Role and Function
    • Structure and People
    • Government Orientation
    • Member States
    • FAQs
  • What We Do
    • Caribbean Regulatory System
    • Communicable Diseases
    • CR-FELTP
    • Data and Health Information
    • Environmental Health
    • Emergency Response
    • Laboratory Services
    • Medicines Quality Control
    • Monitoring and Evaluation
    • Networks
    • Non-Communicable Diseases
    • Nutrition
    • Traveller's Health/THP
    • Vector Borne Diseases
  • Financial Statements
    • 2023 Audited Financial Statements
    • 2022 Audited Financial Statements
    • 2021 Audited Financial Statements
    • 2020 Audited Financial Statements
    • 2019 Audited Financial Statements
    • 2018 Audited Financial Statements
    • 2017 Audited Financial Statements
    • 2016 Audited Financial Statements
  • More
    • CARPHA Foundation
    • CARPHA Projects
    • Digital Library
    • Forum
    • Health Days
    • Internship
      • Call for Interns - Virtual Internship Programme
    • Media
    • Publications and Databases
    • Partner With Us
    • Webinars
    • Work With Us
  • Contact Us
English
EnglishSpanishFrenchDutch
Caribbean Public Health Agency
  • Home
  • Who We Are
    • About
    • Role and Function
    • Structure and People
    • Government Orientation
    • Member States
    • FAQs
  • What We Do
    • Caribbean Regulatory System
    • Communicable Diseases
    • CR-FELTP
    • Data and Health Information
    • Environmental Health
    • Emergency Response
    • Laboratory Services
    • Medicines Quality Control
    • Monitoring and Evaluation
    • Networks
    • Non-Communicable Diseases
    • Nutrition
    • Traveller's Health/THP
    • Vector Borne Diseases
  • Financial Statements
    • 2023 Audited Financial Statements
    • 2022 Audited Financial Statements
    • 2021 Audited Financial Statements
    • 2020 Audited Financial Statements
    • 2019 Audited Financial Statements
    • 2018 Audited Financial Statements
    • 2017 Audited Financial Statements
    • 2016 Audited Financial Statements
  • More
    • CARPHA Foundation
    • CARPHA Projects
    • Digital Library
    • Forum
    • Health Days
    • Internship
      • Call for Interns - Virtual Internship Programme
    • Media
    • Publications and Databases
    • Partner With Us
    • Webinars
    • Work With Us
  • Contact Us

Blood

Home
  • What We Do
  • Laboratory
  • Annex 1-SPECIMEN COLLECTION GUIDELINES
  • Blood

Collection of Blood Speciments

Blood and separated serum are the most common specimens taken to investigate the aetiology of communicable diseases. Venous blood can be used for isolation and identification of pathogens using sub-culture and inoculation techniques. Blood is also separated into serum for the detection of genetic material (e.g. using the polymerase chain reaction), specific antibodies, antigens, or toxins (e.g. by ELISA). For the processing of most specimens for diagnosis of viral pathogens, serum is preferable to un-separated blood except where otherwise directed. When specific antibodies are being assayed, it is often useful to collect paired sera, i.e. an acute sample taken at the onset of illness and a convalescent sample collected one to four weeks later. Blood can also be collected by finger prick for the preparation of slides for microscopy or for absorption onto special filter paper discs for analysis. Whenever possible, blood specimens for culture should be taken before antibiotics are administered to the patient.

NOTE: Collect acute and convalescent blood for serology between 2 and 4 weeks between acute and convalescent specimens.

 

Venous Blood Samples

Materials

SUPPLIES SUPPLIES REAGENTS
  • Disposable latex or vinyl gloves
  • Tourniquet, Vacutainer, Monovette, or similar vacuum blood collection devices, or disposable syringes and needles
  • Vacutainer, blood culture bottles (50ml for adults, 25ml for children) with appropriate media
  • Swabs, gauze pads, band-aid
  • Labels and indelible marker pen.
  • Skin disinfection: 70% alcohol (isopropyl alcohol, ethanol) or 10% povidone, iodine

 

Separation and Collection of Serum from Blood

Materials

EQUIPMENT SUPPLIES REAGENTS
  • Centrifuge
  • Disposable latex or vinyl gloves
  • Tourniquet, Vacutainer, Monovette, or similar vacuum blood collection devices, or disposable syringes and needles
  • Vacutainer, blood culture bottles (50ml for adults, 25ml for children) with appropriate media
  • Swabs, gauze pads, band-aid
  • Labels and indelible marker pen.
  • Sterile Pasteur pipettes and bulb, or soft, disposable transfer pipettes (pastettes). The latter are easy to handle and dispose of in the field laboratory.
  • Sterile screw-cap vials
  • Skin disinfection: 70% alcohol (isopropyl alcohol, ethanol) or 10% povidone, iodine

Procedure

STEP ACTION
1
  • Using the materials (above) and methods described in Section A1.0, draw 10ml of venous blood and transfer to a screw cap tube without anti-coagulant.
  • Alternatively, blood may be collected directly into a proprietary collection and transport tube (e.g., Vacutainer, Monovette, etc.).
2
  • Allow the blood specimen to clot for 30 minutes at ambient temperature
  • The specimen should be centrifuged at the laboratory at low speed (1000g for 10 minutes) to remove residual blood cells.
  • When serum separation is performed in a field laboratory, proper safety precautions should be taken.
  • Ensure that the centrifuge is in good condition and that the tubes are properly closed and balanced to avoid breakage and spilling.
  • If viral haemorrhagic fever is strongly suspected, samples should only be processed in properly equipped, specialized laboratories - Under BSL2+ or BSL3 conditions, using Biosafety Class II A2/B cabinets
  • Discuss with the laboratory personnel whether a separation gel blood tube (see Note) would be acceptable in this case.
3
  • Separate the serum aseptically from the clot using a sterile Pasteur pipette and bulb or soft, disposable transfer pipette.
  • Transfer to a screw cap vial. Secure the cap tightly.
4
  • If a centrifuge is not available and there will be a delay before samples can be transported to a laboratory, serum may still be separated carefully from the retracted clot using a disposable transfer pipette.
  • Allow 4-6 hours to elapse after taking the blood sample to ensure adequate clot retraction.
  • Using the transfer pipette, remove the clear yellow serum whilst taking care to keep the tip as far as possible from the clot, and avoid agitating the blood tube during the removal process. (This may be easier if a separation gel collection tube has been used).
  • Transfer to plastic screw-cap vial and secure cap tightly.
5
  • Label the vial with the same patient details that appear on the blood sample tube.

NOTE: In some instances, it may be acceptable to use a special blood tube containing a separation gel, which encourages separation of serum from clot. In this case, the centrifugation step is eliminated. This has the advantage of ease and safety of specimen processing under field conditions. However, it is important to check with the laboratory in advance to ensure that these devices are appropriate for your particular investigation.

Handling and Transport

  • If serum will be required for testing, separation from blood should take place as soon as possible, preferably within 2 - 3 hours at ambient temperature.
  • If the specimen will not reach a laboratory for processing within 24 hours, serum must, be separated from blood prior to transportation.
  • Sera may be stored at 4-8o for up to 4 days. If serological testing is to be delayed for a longer period, serum samples may be frozen.
  • If separation on site is not possible, or is inadvisable for safety reasons, the blood sample should be stored at 4-8oC.
  • Protect such un-separated samples from excessive vibrations while transporting.
  • Un-separated blood samples should not be frozen.
  • Introduction
  • General Information
  • Specimen Collection Information
  • Testing in Special Circumstances
  • Laboratory Testing Services
  • Download PDF
  • Annex 1-SPECIMEN COLLECTION GUIDELINES
    • Blood
    • Respiratory Tract Samples
    • Cerebrospinal Fluid
    • Faecal Specimens
    • Eye Specimen
    • Samples from Skin Lesions
    • Urine Specimens
    • Sputum Specimens for TB Testing
  • Annex 2 - GUIDELINES FOR PREPARATION, PACKING AND SHIPPING SPECIMENS
  • Annex 3 - Laboratory Investigation Form
  • Annex 4 - CARICOM Invoice
  • Annex 5 - Customer Feedback Form

CARPHA HEAD OFFICE

  • 16-18 Jamaica Blvd,
    Federation Park,
    Port of Spain,
    Trinidad & Tobago
  • (+868) 299-0820
    (+868) 299-0895
    (+868) 622-4261
  • postmaster@carpha.org

CARPHA JAMAICA

  • Hope Gardens,
    Kingston 6,
    Jamaica
  • (+876) 977-3540
    (+876) 702-4235

CARPHA ST. LUCIA

  • P.O. Box 1111,
    The Morne, Castries,
    Saint Lucia
  • (+758) 452-2501
    (+758) 452-1087
  • (+758) 453-2721

Email Us

  • *
  • *
  • *
  • *

Copyright 2022 by The Caribbean Public Health Agency

  • Back to top